ClinicalTrials.gov
public full text
Public Domain
A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
The primary objective of this study is to evaluate the safety of two doses of gefapixant (MK-7264) in Japanese adult participants with refractory or unexplained chronic cough.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.#1086199
- Lessons from the history of cancer screening in Japan between the era of Health and Medical Service Law for the Aged and the era of the Health Promotion Act and the Cancer Control Act#320333
- This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population#1140100
- Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China#369863
- Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities#1058128
Record · ID 881238
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive